In a strongly-worded opinion column for The Indian Express on the Ranbaxy fraud published last week, Amir Attaran of the University of Ottawa rightly calls on the Indian government to do more to ensure that drugs produced in India are safe and effective. But Attaran is wrong is when he uses references to the fraud … Continue reading Guest column : The Ranbaxy fraud has revived the “counterfeits” debate. It shouldn’t.
The EU's industry commissioner says trade in counterfeit medicines in the Union has exceeded its worst fears, according to German daily Die Welt. "The number of counterfeit medicines arriving in Europe ... is constantly growing. The European Commission is extremely worried," the commissioner, Gunter Verheugen, said yesterday. 34 million tablets have been seized in 2 months from … Continue reading Counterfeit drugs : Europe vs India?